(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (Q4129234)
Jump to navigation
Jump to search
Project Q4129234 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | (0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION |
Project Q4129234 in Italy |
Statements
5,000.0 Euro
0 references
10,000.0 Euro
0 references
50.0 percent
0 references
LOGIDEX SRL
0 references
(0350000119) COVID:REALIZZAZIONE DI UN COLLUTORIO A BASE DI RESVERATROLO COMPLESSATO CON CICLODESTRINE PER PREVENIRE IL DIFFONDERSI DEL SARS-COV-2 MEDIANTE AEROSOL SALIVARE: SPERIMENTAZIONE PRECLINICA (Italian)
0 references
(0350000119) COVID:REALIZZAZIONE DE UN ENJUAGUE BUCAL A BASE DE RESVERATROL COMPLEJO CON CICLODEXTRINA PARA PREVENIR LA PROPAGACIÓN DEL SARS-COV-2 POR AEROSOLES SALIVALES: EXPERIMENTACIÓN PRECLÍNICA (Spanish)
30 January 2022
0 references
(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English)
31 January 2022
0 references
(0350000119) COVID:REALIZZAZIONE D’UN BAIN DE BOUCHE À BASE DE RESVÉRATROL COMPLEXE AVEC DE LA CYCLODEXTRINE POUR PRÉVENIR LA PROPAGATION DU SARS-COV-2 PAR LES AÉROSOLS SALIVAIRES: EXPÉRIMENTATION PRÉCLINIQUE (French)
1 February 2022
0 references
TORINO
0 references